VirologyNews.net

Virology Xagena

Search results for "Hepatitis C"

The final statement from the 1st European Consensus Conference on the Treatment of Chronic Hepatitis B and C in HIV Co-infected Patients, includes a definitive recommendation that HIV patients co-infe ...


FDA ( Food and Drug Administration ) has approved Pegasys ( Peginterferon alfa-2a ) and Copegus ( Ribavirin ) for the treatment of chronic hepatitis C in patients co-infected with hepatitis C and HIV. ...


A series of studies by researchers at University of Texas ( UT ) Southwestern Medical Center sheds light on the mechanisms used by viruses to thwart host’s immune defenses and may aid in the developme ...


A study, published in the Journal of Virology, showed that the body's defenses against the virus are random rather than genetically determined. The researchers followed the cases of male twins who ...


A study has found Telaprevir ( VX-950; Incivek, Incivo ), a protease inhibitor, combined with standard hepatitis C treatment, cures a significantly higher number of difficult-to-treat patients th ...


Interim data presented recently have shown that all patients ( 13/13 ) who reached their 4-weeks post-treatment follow-up have undetectable levels of hepatitis C virus ( SVR4 ) after completing a 12-w ...


Results from studies in chronic hepatitis C patients with human immunodeficiency virus type 1 ( HIV-1 ) co-infection ( TURQUOISE-I ) and liver transplant recipients ( CORAL-I ) were presented at The L ...


Data from the ALLY trial investigating a Ribavirin-free 12-week regimen of Daclatasvir ( DCV ) in combination with Sofosbuvir ( SOF ) in genotype 3 hepatitis C ( HCV ) patients, a patient population t ...


The results from a multi-arm phase 2 clinical trial evaluating Grazoprevir / Elbasvir ( MK-5172 / MK-8742, the investigational NS3/4A protease inhibitor and NS5A inhibitor, respectively ) with or wit ...